Literature DB >> 21144415

Influence of sex on left-sided infective endocarditis.

Teresa Sevilla1, Ana Revilla, Javier López, Isidre Vilacosta, Cristina Sarriá, Itziar Gómez, Héctor García, José A San Román.   

Abstract

In many cardiovascular and infectious diseases, there are clinical and prognostic differences between men and women. The aim of this study was to compare the presentation of left-sided infective endocarditis in the two sexes. A total of 621 episodes of left-sided infective endocarditis (395 in men, 226 in women) were studied. The comparative analysis considered epidemiological, clinical, microbiological, echocardiographic and prognostic variables. Despite marked epidemiological, echocardiographic and microbiological differences between men and women, clinical characteristics, treatment approaches and outcomes (in-hospital mortality: 28% in men and 35% in women; P = .1) were similar in our patient series.

Entities:  

Mesh:

Year:  2010        PMID: 21144415     DOI: 10.1016/s1885-5857(10)70285-1

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  3 in total

1.  Sex Differences in Characteristics of Patients with Infective Endocarditis: A Multicenter Study.

Authors:  Ruchi Bhandari; Shabnam Tiwari; Talia Alexander; Frank H Annie; Umar Kaleem; Affan Irfan; Sudarshan Balla; R Constance Wiener; Chris Cook; Aravinda Nanjundappa; Mark Bates; Ellen Thompson; Gordon S Smith; Judith Feinberg; Melanie A Fisher
Journal:  J Clin Med       Date:  2022-06-18       Impact factor: 4.964

Review 2.  Short- and long-term outcomes in infective endocarditis patients: a systematic review and meta-analysis.

Authors:  Tadesse Melaku Abegaz; Akshaya Srikanth Bhagavathula; Eyob Alemayehu Gebreyohannes; Alemayehu B Mekonnen; Tamrat Befekadu Abebe
Journal:  BMC Cardiovasc Disord       Date:  2017-12-12       Impact factor: 2.298

3.  Sex-related disparities in the incidence and outcomes of infective endocarditis according to type 2 diabetes mellitus status in Spain, 2016-2020.

Authors:  Ana Lopez-de-Andres; Rodrigo Jimenez-Garcia; Valentin Hernández-Barrera; Javier de-Miguel-Díez; Jose M de-Miguel-Yanes; David Martinez-Hernandez; David Carabantes-Alarcon; Jose J Zamorano-Leon; Concepción Noriega
Journal:  Cardiovasc Diabetol       Date:  2022-09-30       Impact factor: 8.949

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.